Kura Oncology COO Kathleen Ford receives $3.5M in 2019
Kura Oncology reports 2019 executive compensation
By ExecPay News
Published: April 28, 2020
Kura Oncology reported fiscal year 2019 executive compensation information on April 28, 2020.
In 2019, six executives at Kura Oncology received on average a compensation package of $2.5M, a 18% decrease compared to previous year.
Average pay of disclosed executives at Kura Oncology
Kathleen Ford, Chief Operating Officer, received $3.5M in total. 93% of Ford's compensation, or $3.2M, was in option awards. Ford also received $62K in non-equity incentive plan, $158K in salary, as well as $31K in other compensation.
Troy E. Wilson, Chief Executive Officer, received a compensation package of $3.2M, which decreased by 32% compared to previous year. 72% of the compensation package, or $2.3M, was in option awards.
John Farnam, Chief Operating Officer, earned $2.2M in 2019, a 26% increase compared to previous year.
Marc Grasso, Chief Financial Officer, received $2.1M in 2019, which decreases by 42% compared to 2018.
Antonio Gualberto, Chief Medical Officer, earned $2.1M in 2019, a 1% increase compared to previous year.
James Basta, Chief Legal Officer, received $1.9M in 2019.
Related executives
You may also like
Source: SEC filing on April 28, 2020.